PVA-based formulations as a design-technology platform for orally disintegrating film matrices

[Display omitted] •The application of weak non-salt forming lactic acid as a solubilizer enabled the dissolution of poorly soluble haloperidol.•Spray-drying enabled production of a homogenous PVA/HAL blend with low API content for hot melt extrusion.•The selection of manufacturing method was found t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2024-11, Vol.665, p.124666, Article 124666
Hauptverfasser: Kozakiewicz-Latała, Marta, Dyba, Aleksandra J., Marciniak, Dominik, Szymczyk-Ziółkowska, Patrycja, Cieszko, Mieczysław, Nartowski, Karol P., Nowak, Maciej, Karolewicz, Bożena
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •The application of weak non-salt forming lactic acid as a solubilizer enabled the dissolution of poorly soluble haloperidol.•Spray-drying enabled production of a homogenous PVA/HAL blend with low API content for hot melt extrusion.•The selection of manufacturing method was found to influence the HAL diffusion.•The processing-structure–property relationships were evaluated. In the majority of pharmaceutical applications, polymers are employed extensively in a diverse range of pharmaceutical products, serving as indispensable components of contemporary solid oral dosage forms. A comprehensive understanding of the properties of polymers and selection the appropriate methods of characterization is essential for the design and development of novel drug delivery systems and manufacturing processes. Orally disintegrating film (ODF) formulations are considered to be a potential substitute to traditional oral dosage forms and an alternative method of drug administration for children and uncooperative adult patients, including those with swallowing difficulties. A multitude of pharmaceutical formulations with varying mechanical and biopharmaceutical properties have emerged from the modification of the original polymeric bulk. Here we propose different formulation approaches, i.e. solvent casting (SC), 3D printing (3DP), electrospinning (ES), and lyophilization (LP) that enabled us to adjust the disintegration time and the release profile of poorly water soluble haloperidol (HAL, BCS class II) from PVA (polyvinyl alcohol) based polymer films while maintaining similar hydrogel composition. In this study, the solubility of haloperidol in aqueous solution was improved by the addition of lactic acid. The prepared films were evaluated for their morphology (SEM, micro-CT), physicochemical and biopharmaceutical properties. TMDSC, TGA and PXRD were employed for extensive thermal and structural analysis of fabricated materials and their stability. These results allowed us to establish correlations between preparation technology, structural characteristics and properties of PVA films and to adapt the suitable manufacturing technique of the ODFs to achieve appropriate HAL dissolution behaviour.
ISSN:0378-5173
1873-3476
1873-3476
DOI:10.1016/j.ijpharm.2024.124666